Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial

Autor: Philis-Tsimikas, Athena *, Asong, Marisse, Franek, Edward, Jia, Ting, Rosenstock, Julio, Stachlewska, Karolina, Watada, Hirotaka, Kellerer, Monika
Zdroj: In The Lancet Diabetes & Endocrinology June 2023 11(6):414-425
Databáze: ScienceDirect